Yorktown Management & Research Company’s Thermo Fisher Scientific TMO Stock Holding History

Yorktown Management & Research Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-443	Closed	-$241K	–	226
2022 Q2	$241K	Hold	443	–	–	0.31%	143
2022 Q1	$262K	Hold	443	–	–	0.22%	178
2021 Q4	$296K	Sell	443 -47	-10%	-$29.3K	0.2%	191
2021 Q3	$280K	Hold	490	–	–	0.21%	191
2021 Q2	$247K	Hold	490	–	–	0.19%	220
2021 Q1	$224K	Sell	490 -460	-48%	-$220K	0.19%	222
2020 Q4	$442K	Sell	950 -900	-49%	-$422K	0.4%	107
2020 Q3	$817K	Buy	1,850 +950	+106%	+$392K	0.76%	17
2020 Q2	$326K	Hold	900	–	–	0.29%	139
2020 Q1	$255K	Hold	900	–	–	0.26%	156
2019 Q4	$292K	Hold	900	–	–	0.16%	198
2019 Q3	$262K	Sell	900 -400	-31%	-$115K	0.14%	213
2019 Q2	$382K	Hold	1,300	–	–	0.14%	182
2019 Q1	$356K	Hold	1,300	–	–	0.12%	208
2018 Q4	$291K	Buy	+1,300	New	+$305K	0.1%	226
2014 Q3	–	Sell	-1,900	Closed	-$224K	–	492
2014 Q2	$224K	Hold	1,900	–	–	0.04%	402
2014 Q1	$228K	Hold	1,900	–	–	0.04%	380
2013 Q4	$212K	Buy	+1,900	New	+$189K	0.04%	371

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Yorktown Management & Research Company's TMO Position: Q3 2022 in Review

Yorktown Management & Research Company sold out of Thermo Fisher Scientific (TMO) in Q3 2022, closing a stake of 443 shares — an estimated $241K sold.

Yorktown Management & Research Company first reported a position in TMO in Q4 2013 and held it in 18 quarters. The position peaked at $817K in Q3 2020. 2,267 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

Yorktown Management & Research Company reported no remaining Thermo Fisher Scientific position as of Q3 2022 after selling out during the quarter.
Yorktown Management & Research Company sold 443 Thermo Fisher Scientific shares in Q3 2022, an estimated $241K.
Yorktown Management & Research Company first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 18 quarters.
Yorktown Management & Research Company's Thermo Fisher Scientific position peaked at $817K in Q3 2020.
2,267 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Yorktown Management & Research Company's 13F filing for Q3 2022, filed 4 Nov 2022.